Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| 2',3'-Dideoxy-3'-fluorouridine | 2',3'-Dideoxy-3'-fluorouridine is a reactant used in the synthesis of 5'-trityl nucleosides to inhibit Plasmodium falciparum dUTPase. It exhibits anti-retrovirus activity. Group: Pharmaceutical. CAS No. 41107-56-6. Pack Sizes: 100 mg. Product ID: B2706-316809. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| 2'-Amino-2'-deoxyuridine | 2'-Amino-2'-deoxyuridine, a nucleoside analogue, finds its use in chemotherapy as an anti-cancer agent. Its ability to cause DNA damage and trigger apoptosis in cancer cells stem from its selective integration in cancer cell DNA. Additionally, it offers immense potential in the field of oncology research, studying tumor cell differentiation and proliferation. Group: Pharmaceutical. CAS No. 26889-39-4. Pack Sizes: 1 g. Product ID: B2706-089006. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-Chloro-2'-deoxyuridine | 2'-Chloro-2'-deoxyuridine (CAS# 4753-04-2 ) is a useful research chemical. Group: Pharmaceutical. CAS No. 4753-4-2. Pack Sizes: 500 mg. Product ID: B2706-118947. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-Deoxy-2'-fluoro-5-iodouridine | It is an antiviral drug and nucleoside analogue with anti-hepatitis B activity. Group: Pharmaceutical. CAS No. 55612-21-0. Pack Sizes: 100 mg. Product ID: B1370-261441. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-Deoxy-5-methoxyuridine | 2'-Deoxy-5-methoxyuridine is a nucleoside analog with antiviral potency. It can selectively inhibit the replication of viral genetic material and has been shown to be effective against HIV-1. Group: Pharmaceutical. CAS No. 37805-95-1. Pack Sizes: 10 mg. Product ID: B1370-058151. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 2'-Deoxyuridine | 100g Pack Size. Group: Biochemicals, Pyrimidines, Research Organics & Inorganics. Formula: C9H12N2O5. CAS No. 951-78-0. Prepack ID : 61613969-100g. Molecular Weight : 228.2. |  |
| 2'-Deoxyuridine | 25g Pack Size. Group: Biochemicals, Pyrimidines, Research Organics & Inorganics. Formula: C9H12N2O5. CAS No. 951-78-0. Prepack ID : 61613969-25g. Molecular Weight : 228.2. | |
| 2'-Deoxyuridine | 5g Pack Size. Group: Biochemicals, Pyrimidines, Research Organics & Inorganics. Formula: C9H12N2O5. CAS No. 951-78-0. Prepack ID : 61613969-5g. Molecular Weight : 228.2. | |
| 2'-Deoxyuridine-5'-triphosphate trisodium salt | dUTP is a deoxynucleoside triphosphate (dNTP) that acts as a substrate for several enzymes. It can be used in PCR and qPCR. Group: Pharmaceutical. CAS No. 102814-08-4. Pack Sizes: 500 mg. Product ID: B1370-081015. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| (2'R)-2'-deoxy-2'-fluoro-2'-C-methyluridine | PSI-6206 is a selective HCV RNA polymerase inhibitor. It is the unphosphorylated parent compound of triphosphate analog PSI-7409, which is a potent inhibitor of the HCV NS5B RNA dependent RNA polymerase. Group: Pharmaceutical. CAS No. 863329-66-2. Pack Sizes: 5 g. Product ID: B2693-459960. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-Amino-3'-deoxyuridine | 3'-Amino-3'-deoxyuridine, a multifaceted compound extensively utilized in the biomedical sector, assumes a pivotal function in the fabrication of antiviral medications, specifically those combatting DNA viruses such as herpes simplex virus (HSV). Moreover, it serves as a fundamental constituent in the formulation of nucleoside analogs, augmenting their efficacy in combating viral ailments, including cancer. Group: Pharmaceutical. CAS No. 70580-90-4. Pack Sizes: 100 mg. Product ID: B2706-337977. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-Deoxy-3'-fluorouridine | 3'-Deoxy-3'-fluorouridine, a compound of utmost significance in the biomedical industry, assumes a pivotal position in the advancement of antiviral pharmaceuticals targeting RNA virus-associated ailments. This exceptional product showcases its robust antiviral efficacy against a multitude of viruses. Through the powerful mechanism of inhibiting viral replication, 3'-Deoxy-3'-fluorouridine emerges as a propitious contender in the ongoing battle against these formidable infectious maladies. Group: Pharmaceutical. CAS No. 57944-13-5. Pack Sizes: 5 mg. Product ID: B2706-279822. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 3'-O-(t-Butyldimethylsilyl)-2'-deoxy-2'-fluorouridine | 3'-O-(t-Butyldimethylsilyl)-2'-deoxy-2'-fluorouridine is a highly complex and perplexing compound, playing a pivotal role in combatting viruses. Notably, it showcases exceptional selectivity and efficacy against viral replication and tumor proliferation, thereby emerging as an indispensable asset in the development of antiviral medicines and anticancer researchs. Group: Pharmaceutical. CAS No. 1445379-59-8. Pack Sizes: 1 g. Product ID: B1370-072091. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2'-deoxyuridine | 5-[3-(Trifluoroacetamido)-E-1-propenyl]-2'-deoxyuridine is a potent antiviral agent utilized in the treatment of viral infections caused by herpes simplex viruses (HSV-1, HSV-2), varicella-zoster virus (VZV), and Epstein-Barr virus (EBV). This compound inhibits viral DNA replication, reducing viral propagation and promoting host recovery. Its mechanism of action involves the incorporation into viral DNA, leading to chain termination. Group: Pharmaceutical. CAS No. 115794-55-3. Pack Sizes: 1 g. Product ID: B0001-331230. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-Bromo-2'-deoxyuridine | 1g Pack Size. Group: Biochemicals, Research Organics & Inorganics. Formula: C9H11BrN2O5. CAS No. 59-14-3. Prepack ID : 14886197-1g. Molecular Weight : 307.1. | |
| 5-Bromo-2'-deoxyuridine | 5g Pack Size. Group: Biochemicals, Research Organics & Inorganics. Formula: C9H11BrN2O5. CAS No. 59-14-3. Prepack ID : 14886197-5g. Molecular Weight : 307.1. | |
| 5-Chloro-2'-deoxyuridine | It is an anticancer agent and a radio-sensitizing agent for cancer treatment. Group: Pharmaceutical. CAS No. 50-90-8. Pack Sizes: 1 g. Product ID: B1370-179178. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-Fluoro-2'-deoxyuridine | 1g Pack Size. Group: Biochemicals, Building Blocks. Formula: C9H11FN2O5. CAS No. 50-91-9. Prepack ID : 27134875-1g. Molecular Weight : 246.19. | |
| 5-Fluoro-2'-deoxyuridine-5'-triphosphate (triethylammonium salt form) | An impurity of UTP. UTP is a pyrimidine nucleoside triphosphate as a substrate in the biosynthesis of RNA. Group: Pharmaceutical. CAS No. 1621676-99-0. Pack Sizes: 1 mg. Product ID: B1331-007255. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-Fluoro-5'-deoxyuridine | 5g Pack Size. Group: Biochemicals. Formula: C9H11FN2O5. CAS No. 3094-9-5. Prepack ID : 10130089-5g. Molecular Weight : 246.2. | |
| 5-(Hydroxymethyl)-2'-deoxyuridine | 5-(Hydroxymethyl)-2'-deoxyuridine is a nucleoside analog with anticancer and antiviral activities. It inhibits the replication of murine S180 lung carcinoma cells and Ehrlich ascites mammary carcinoma cells (ED50s = 8.5 and 4 μM, respectively) and multiple human leukemia cell lines (IC50s = 1.7-5.8 μM). 5-(Hydroxymethyl)-2'-deoxyuridine acts synergistically with 5-fluorouracil (5-FU) against HT-29, HCT116, PANC-1, and EKVX cancer cells with no effect on WI38 embryonic lung fibroblasts. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 5116-24-5. Pack Sizes: 1 g. Product ID: B1370-120698. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-Hydroxymethyl-2'-deoxyuridine 5'-monophosphate Sodium | 5-Hydroxymethyl-2'-deoxyuridine 5'-monophosphate Sodium is a nucleotide that can be used in DNA bioresearch and repair, as well as cancer treatment. It inhibits the synthesis of DNA by binding to the enzyme DNMT1 and causing it to lose its ability to produce DNA. It also suppresses RNA synthesis to induce cell death. Group: Pharmaceutical. CAS No. 160509-68-2. Pack Sizes: 10 mg. Product ID: B2693-076438. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5-Iodo-2-deoxyuridine | 1g Pack Size. Group: Biochemicals, Pyrimidines. Formula: C9H11IN2O5. CAS No. 54-42-2. Prepack ID : 27287319-1g. Molecular Weight : 354.1. | |
| 5-Iodo-2-deoxyuridine | 5g Pack Size. Group: Biochemicals, Pyrimidines. Formula: C9H11IN2O5. CAS No. 54-42-2. Prepack ID : 27287319-5g. Molecular Weight : 354.1. | |
| 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite | 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxy-2'-fluorouridine-3'-(2-cyanoethyl-N,N-diisopropyl)phosphoramidite (CAS# 146954-75-8) is a useful research chemical. Group: Pharmaceutical. CAS No. 146954-75-8. Pack Sizes: 5 g. Product ID: B2706-084339. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-2'-deoxyuridine-3'-CE Phosphoramidite | 5'-O-DMT-2'-deoxyuridine-3'-CE Phosphoramidite stands as an indispensable entity within the realm of biomedicine, wherein its applications for the synthesis of nucleic acids in investigative capacities hold paramount significance. DNA and RNA oligonucleotides rely on this product as their cornerstone, as it seamlessly integrates 2'-deoxyuridine into nucleic acid sequences with exacting efficiency. Aiding the progression of pharmaceutical innovation, gene therapy, and genetic exploration, it emerges as an invaluable instrument that propels advancements in the remediation of diverse medical afflictions. Group: Pharmaceutical. CAS No. 109389-30-2. Pack Sizes: 10 g. Product ID: B2706-252233. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| 5'-O-DMT-5-Fluoro-2'-deoxyuridine-3'-CE Phosphoramidite | 5'-O-DMT-5-Fluoro-2'-deoxyuridine-3'-CE Phosphoramidite is a highly potent reagent for the synthesis of 5-fluorouracil (5-FU) containing oligonucleotides, with potential applications in the treatment of cancer. By boosting the selectivity and efficacy of 5-FU, a well-established chemotherapy drug for different forms of cancer, this compound constitutes a promising avenue to enhance the therapeutic options available to patients. Group: Pharmaceutical. CAS No. 142246-63-7. Pack Sizes: 250 mg. Product ID: B2706-049657. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Bromodeoxyuridine (BrdU) | 5-Bromo-2'-deoxyuridine (5-BrdU) is a thymidine analog that can be incorporated into newly synthesized DNA to label it. Group: Pharmaceutical. CAS No. 59-14-3. Pack Sizes: 5 g. Product ID: B2706-004257. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Fiacitabine | Fiacitabine is a selective inhibitior of DNA replication of herpes simplex virus(HSV). It was active at much lower concentrations than arabinosylcytosine, iododeoxyuridine, and arabinosyladenine. It was slightly more active against herpes simplex virus type 1 than acycloquanosine and slightly more toxic to normal cells. Uses: Antineoplastic agents. Group: Pharmaceutical. CAS No. 69123-90-6. Pack Sizes: 10 mg. Product ID: B2693-097087. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Sofosbuvir | Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Uses: Antiviral agents. Group: Pharmaceutical. CAS No. 1190307-88-0. Pack Sizes: 2.5 g. Product ID: B0084-457411. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| TAS-102 | TAS-102 is a combination drug composed of the cytotoxic pyrimidine analog Trifluridine (5-trifluoro-2'-deoxythymidine or TFT) and a thymidine phosphorylase inhibitor (TPI) tipiracil hydrochloride, in a molar ratio of 1.0:0.5 (TFT:TPI). TAS-102 is used as a third- or fourth-line treatment of metastatic colorectal cancer. Group: Pharmaceutical. CAS No. 733030-01-8. Pack Sizes: 50 mg. Product ID: B0046-462799. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
